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Abstract 
 
Introduction 
Pneumovesical ureteric reimplantation has gained increasing popularity for the treatment 
of vesicoureteric reflux and vesicoureteric junction obstruction in pediatric patients. In 
this study we reviewed our experience at an intermediate term basis. 
 
Methods 
A retrospective review of all patients with pneumovesical ureteric reimplantation 
performed in a tertiary referral centre between 2005 and 2015 was carried out. Patients' 
demographics, operative measures and post-operative outcomes were recorded. 
 
Results 
31 patients were identified during the study period. 23 patients had vesicoureteric reflux 
and 8 patients had vesicoureteric junction obstruction. A total of 42 ureteric 
reimplantation procedures were carried out. The mean age at operation was 6.1 years old. 
The mean operative time was 221 minutes. On average the length of hospital stay was 7.4 
days. 4 patients required conversion to open approach. 4 patients had low grade residual 
vesicoureteric reflux after the operation and all of them were treated conservatively. 
There was no major complication or mortality. 
 
Conclusion 
Pneumovesical ureteric reimplantation is safe and effective for pediatric patients. 
Intermediate term result confirmed its reliability and low recurrence rate. It has good 
potential to become the preferred approach of choice in the future. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
Disease process involving the vesicoureteric junction is a common problem in pediatric 
urology practice. Vesicoureteric reflux (VUR) and vesicoureteric junction obstruction 
(VUJO) comprise the majority of this condition. Ureteric reimplantation remains the 
definitive treatment for patients with VUJO. While there are different choices for the 
management of VUR, ureteric reimplantation serves as the ultimate option for patients 
who failed medical treatment or endoscopic therapy1. 
 
Different surgical techniques of ureteric reimplantation have been reported, including 
both intravesical and extravesical approach2, 3. In recent years minimal invasive approach 
has become an increasingly popular alternative to traditional open ureteric reimplantation. 
Laparoscopic extravesical ureteric reimplantation was first described by Lakshmanan et 
al in 20004. Later Yeung et al reported the technique of minimal invasive intravesical 
cross-trigonal ureteric reimplantation using pneumovesicum with the advantage to avoid 
intraperitoneal complication5. 
 
Previously we have reported our early series with the first few cases of laparoscopic 
pneumovesical ureteric reimplantation in 20086. Here we reviewed the results of our 
patients at an intermediate term basis after a decade of experience. 
 
Materials and methods 
This is a retrospective review of all pediatric patients with pneumovesical ureteric 
reimplantation performed in our centre between January 2005 and December 2015. 
Medical and operative records were retrieved for study. Patients' demographics, pre-
operative diagnoses, operative measures and post-operative outcomes were extracted 
from the records. 
 
All patients received either voiding cystourethrogram or MAG-3 scan before the 
operation to confirm their diagnosis. For VUR patients, operation was offered to those 
with high grade disease (grade IV to V) or to patients with low grade disease but 
presented with breakthrough urinary tract infection despite compliant to antibiotics. 
Patients with residual high grade VUR or recurrent urinary tract infection following 
previous endoscopic injection therapy were also considered as indication for operation. 
Similarly, all patients with significant VUJO on MAG-3 scan were offered operation. 
 
The pneumovesical operative technique was similar to previously described5, 6, which 
involves bladder insufflation with carbon dioxide to create pneumovesicum. Following 
bladder anchoring and insertion of three 5mm Step ports, the distal ureter was dissected 
out same as the open Cohen method. The freed distal ureter was then brought through a 
submucosal tunnel created over the bladder trigone, and subsequently anchored using 
monofilament nonabsorbable sutures. The operative technique was similar for both VUR 
and VUJO patients. Patients were discharged home once they became asymptomatic with 
all catheters removed. After the operations, voiding cystourethrogram or MAG-3 scan 
was performed at 3 months interval to assess any residual or recurrent disease. 
 
Results 
A total of 31 patients were identified during the study period. 9 males and 22 females. 
The mean age at operation was 6.1± 0.6 years old (range 1-17 years). 23 patients had 
VUR confirmed on voiding cystourethrogram while 8 patients had evidence of significant 
VUJO on MAG-3 scan. 2 VUR patients were associated with ureteroceles. 11 patients 
(35%) had bilateral disease and required bilateral reimplantation. Otherwise the laterality 
of involvement was similar in patients with single sided disease. 
 
 A total of 42 ureteric reimplantation procedures were performed. The mean operative 
time was 221 ± 7 minutes (range 169-318 minutes). 4 patients required conversion to 
open approach. 3 of them were converted due to significant adhesion and fibrosis 
following previous endoscopic dextranomer-hyaluronic acid compound injection around 
the ureteric orifice. Another patient was converted because of persistent air leak and 
failure to maintain the pneumovesicum. On average the length of hospital stay was 7.4 ± 
0.8 days (range 3-22 days). No mortality or major complication was noted. 4 patients had 
low grade residual VUR after the operation and all of them were treated conservatively. 
No recurrence of either VUR or VUJO was seen on post-operative imaging studies. 
 
Discussion 
The development of pneumovesical ureteric reimplantation has come its long way since 
the end of last century. The concept of minimally invasive approach for ureteric 
reimplantation was first attempted by Atala et al in an extravesical approach on a porcine 
model in 19937. However the experience from past open surgery has warned surgeons 
against the potential risk to develop voiding dysfunction in patients who underwent 
extravesical reimplantation. In addition extravesical approach nevertheless carries the risk 
of damaging intraperitoneal structure during operation. Working in the limited pelvic 
space in children can also be very difficult even in a laparoscopic environment. The 
breakthrough did not arrive until Gill et al reported the new technique of laparoscopic 
cross-trigonal reimplantation in 20018. Yeung et al further modified the operation with 
the use of carbon dioxide pneumovesicum5. It provides a better and clearer intravesical 
view by avoiding the fluid turbidity. A good working space can also be developed with 
the use of a reasonable intravesical pressure between 8 to 10 mm Hg. It also made the 
placement of transurethral suction catheter possible, which is an effective means to 
remove urine or blood from the bladder during operation. 
 
VUR was still the main indication for ureteric reimplantation9, 10. The best treatment 
approach for VUR is yet a highly debatable topic11. Despite the wider application of 
endoscopic injection therapy, some patients have residual reflux with repeated injections1. 
The low residual or recurrence rate from our data means that pneumovesical approach is 
a safe alternative. 4 of our VUR procedures were found to have residual disease after 
operation, all of them being low grade and were managed successfully with conservative 
treatment. Interestingly in the 4 patients who required conversion to open approach, 3 of 
them had previous history of endoscopic injection therapy. We postulated that it was the 
dextranomer-hyaluronic acid compound injected around the ureteric orifice previously 
which resulted in severe adhesion and fibrosis, making distal ureter dissection difficult 
and required a conversion. Pneumovesical reimplantation may therefore be justified as 
the first line treatment in patients with high grade reflux owing to the increased operative 
difficulty and risks following previous endoscopic injection treatment. 
 
The use of pneumovesical reimplantation has extended beyond its original application on 
VUR to include VUJO into the spectrum. There had been recent studies by Bi et al and 
Liu et al focusing mainly on primary obstructive megaureter12, 13. Conclusion from these 
studies all agreed that the pneumovesical approach is as effective as traditional open 
reimplantation. Bi et al employed the same cross-trigonal approach as we described and 
the result has been highly successful with only one residual obstruction out of the 61 
procedures performed. Liu et al also reported improvement in over 90% of cases. Data 
from our series concurred with the above findings with no residual or recurrent 
obstruction seen in any of the VUJO patients after the operation.  
 
In conclusion, pneumovesical ureteric reimplantation is safe and effective for pediatric 
patients. It can be applied to patients with VUR and VUJO. Intermediate term result 
confirmed its reliability and low recurrence rate. It has good potential to become the 
preferred approach of choice in the future. 
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